Although GLP-1R agonists have been shown to be the most successful agents for weight loss, these drugs also have their limitations
Campillo-Navarro M, Leyva-Paredes K, Donis-Maturano L, Rodriguez-Lopez GM, Soria-Castro R, Garcia-Perez BE, Puebla-Osorio N, Ullrich SE, Luna-Herrera J, Flores-Romo L, Sumano-Lopez H, Perez-Tapia SM, Estrada-Parra S, Estrada-Garcia I, Chacon-Salinas R (2018) Mycobacterium tuberculosis catalase inhibits the formation of mast cell extracellular traps
Most intriguingly, inflammation has a major role in the etiology of BPH 45,93,94,95
Levothyroxine requirements typically increase by 25% to 50% during pregnancy, per Alexander et al
doi: 10.1186/1475-2891-9-10
In real-world clinical practice, results vary by individual but tirzepatide consistently produces greater weight loss than any previous approved weight loss medication